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Neuronal activity regulates remyelination via
glutamate signalling to oligodendrocyte progenitors
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Myelin regeneration can occur spontaneously in demyelinating diseases such as multiple
sclerosis (MS). However, the underlying mechanisms and causes of its frequent failure
remain incompletely understood. Here we show, using an in-vivo remyelination model, that
demyelinated axons are electrically active and generate de novo synapses with recruited
oligodendrocyte progenitor cells (OPCs), which, early after lesion induction, sense neuronal
activity by expressing AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)/kai-
nate receptors. Blocking neuronal activity, axonal vesicular release or AMPA receptors in
demyelinated lesions results in reduced remyelination. In the absence of neuronal activity
there is a B6-fold increase in OPC number within the lesions and a reduced proportion of
differentiated oligodendrocytes. These ﬁndings reveal that neuronal activity and release
of glutamate instruct OPCs to differentiate into new myelinating oligodendrocytes that
recover lost function. Co-localization of OPCs with the presynaptic protein VGluT2 in MS
lesions implies that this mechanism may provide novel targets to therapeutically enhance
remyelination.
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R
emyelination of the central nervous system (CNS) axons is
essential for functional recovery after demyelinating
injuries. It can occur as a spontaneous regenerative process
in multiple sclerosis (MS) and other neurological conditions,
including spinal cord injury. Oligodendrocyte progenitor cells
(OPCs), which comprise B5% of all cells in the adult CNS and
are the principal proliferative cell type1, respond to demyelinating
injury by differentiating into myelinating oligodendrocytes to
restore function2,3. This regenerative process is controlled
by a precisely orchestrated but still incompletely understood
array of signalling events4. However, remyelination often fails,
primarily owing to failure of OPC lineage progression rather
than a depletion of OPCs, many of which persist in chronic
demyelinated lesions5. Thus, many attempts at promoting
remyelination therapeutically have focused on the control of
OPC differentiation. A critical feature of the injury environment
that has been largely overlooked is the demyelinated axon and the
role it might play in regulating OPC lineage progression during
remyelination.
In development, white matter OPCs express glutamate
receptors6,7 and receive synaptic input6,8–11 from unmyelinated
axons9,10, enabling them to monitor and respond to neuronal
activity. Both the synaptic input and glutamate signalling regulate
OPC proliferation11,12 and myelination13–16, although neuronal
activity is not essential for myelination13,17. In demyelinated
lesions of the corpus callosum OPCs and progenitor cells
recruited from the sub-ependymal zone receive synaptic input
from axons18,19. However, it is unclear whether this input is from
unmyelinated corpus callosal axons, as up to 70% of callosal
axons are unmyelinated20, or from demyelinated axons that
generate de novo synapses to recruited OPCs. Even less is
known of the effects of such signalling on remyelination.
Moreover, it is uncertain of the extent to which glutamate
exacerbates demyelination via excitotoxicity21,22 or promotes
remyelination13,23.
Here we show that demyelinated axons generate synaptic
contacts to OPCs, and that neuronal activity regulates remyelina-
tion, by synaptic release of glutamate, instructing OPCs to
differentiate into new myelinating oligodendrocytes.
Results
The toxin-induced demyelination model. To investigate the
signalling between demyelinated axons and OPCs within a
demyelinated area, we used a toxin-induced focal demyelinating
lesion (Fig. 1a,b). In this model, there is little axonal pathology
and remyelination proceeds to completion with a clear temporal
separation between the acute demyelination phase and the sub-
sequent stages of remyelination24,25. Moreover, the adult rat
caudal cerebellar peduncle (CCP) is fully myelinated at the time
of toxin injection; thus, all bare axons are demyelinated axons
(Supplementary Fig. 1 and see Methods)24.
First, we addressed whether demyelinated axons in the CCP
conduct action potentials (Fig. 1c–g). During developmental
myelination of the CCP, there is a clear separation between the
conduction speed of myelinated and unmyelinated axons
(Fig. 1d). However, at 3 months of age, at the time of lesion
induction, the latency peak associated with conduction in
unmyelinated axons was undetectable (Fig. 1e, black trace),
indicating that all CCP axons are myelinated at this time. To
determine whether the demyelinated axons can still conduct, we
recorded from the lesions at 7 days post lesion (dpl), at the time
when OPC recruitment is at its maximum25 (Fig. 1j,l). We found
that demyelinated axons conducted action potentials with a speed
(0.29±0.04m s 1, at room temperature) similar to that of
unmyelinated axons during development (0.45m s 1 at p19;
Fig. 1d,e), thus demonstrating that all the axons within the focal
CCP lesion are demyelinated but, most importantly, are capable
of impulse conduction. Recovery of fast action potential
propagation was established by 21 dpl, when remyelination is
largely complete (Fig. 1f,g), with conduction speeds identical to
those of the pre-lesion adult CCP (1.12±0.13 versus
0.99±0.12m s 1, respectively; P¼ 0.48, one-way analysis of
variance (ANOVA) followed by Holm–Bonferroni test, n¼ 5)
and signiﬁcantly faster than at 7 dpl (P¼ 0.008, one-way ANOVA
followed by Holm–Bonferroni test, n¼ 3). Therefore, we have
clearly established that in this lesion model demyelinated axons
can conduct, with the speed of unmyelinated axons, and there is a
full functional recovery of conduction speed on remyelination.
Although remyelination generates thinner myelin than
developmental myelination26, the resulting internodes are
shorter27, which, along with other changes such as nodal
geometry and voltage-gated sodium channel density, may
compensate for the thinner myelin28 and restore the
conduction velocity to its normal value29.
Second, we investigated the cellular proﬁle of the demyelinat-
ing lesion as it progresses from demyelination to remyelination.
Ethidium bromide (EB) is cytotoxic and will damage all nucleated
cell types but leaves the axons intact (Supplementary Fig. 1 and
see Methods)24; thus, all cells within the repairing lesion are
recruited from surrounding tissue. As previously demonstrated
for early timepoints24, we found that the lesions lack astrocytes
(Fig. 1h,i,l); however, at 14 dpl astrocytes emerge from the lesion
edge and at 21 dpl they have fully re-colonized the lesion, but
appear slightly more immunoreactive to glial ﬁbrillary acidic
protein (GFAP) than in the adjacent normal-appearing white
matter. OPCs (NG2þ and Olig2þ ) are present at 3 dpl25,30 and
reach a much higher density than in normal-appearing adult
Figure 1 | The toxin-induced demyelination model. (a) Demyelinated lesions were created by injection of 0.01% EB into the rat CCP (Crb, cerebellum).
(b) Acute cerebellum and brainstem section containing a lesion in the CCP (delineated by dashed lines). The needle track going through the cerebellum is
visible on the left of the vertical dashed line. Scale bar, 2mm. (c) Fixed section after compound action potential recording, the lesion (delineated by dashed
lines) is visible with 4,6-diamidino-2-phenylindole (DAPI) staining due to increased macrophages and OPC inﬁltration; the location of stimulating (stim,
dark blue DiD) and recording (rec, red DiI) electrodes are marked. Scale bar, 200mm. (d–f) TTX-subtracted compound action potential recordings. (d) At
p19, peaks for both myelinated (M) and non-myelinated axons (NM) were detected. (e,g) At 7 dpl, demyelinated axons (grey trace) have a peak latency
similar to non-myelinated axons, whereas (f,g) when remyelinated at 21 dpl (grey trace) the peak latency is similar to adult myelinated axons (black trace).
Numbers of brain slices are shown on bars. Data represent means±s.e.m. The P-value is from Holm–Bonferroni post-hoc test after a one-way ANOVA
(P¼0.003). (h) Timeline of GFAP expression in CCP lesions at 3, 7, 14 and 21 dpl; scale bar, 200mm, (i) Magniﬁed images from h of the regions indicated
by the white box. (j) Timeline of oligodendrocyte lineage cells in the lesion, with Olig2þ and NG2þ OPCs, and (k) CC1þ oligodendrocytes. Scale bars,
20mm. (l) Diagram showing the peak appearance of oligodendrocytes, OPCs and astrocytes in the CCP following EB lesion. The red shaded area marks the
timing of the EB injection and the onset of demyelination with the associated death of all nucleated cell types within the lesion. Re-colonization of the lesion
occurs as follows: OPCs arrive in the lesion and proliferate before differentiating into oligodendrocytes. Astrocytes start to repopulate the lesion in week 2.
The orange shading indicates the remyelination process; darker orange corresponds to more remyelination.
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white matter at 5–7 dpl (Fig. 1j,l), but by 21 dpl their numbers
have declined to near-normal adult white matter levels. Staining
for CC1, a marker of differentiated oligodendrocytes, at 3 dpl is
punctate/globular and is likely to be the postdemyelination
remnants of antigen present within phagocytic macrophages. We
detected few differentiated oligodendrocytes (CC1þ ) at 7 dpl
(Fig. 1k,l), but their numbers overshot at 14 dpl before decreasing
to reach a density similar to that in normal-appearing white
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matter at 21 dpl (Fig. 1k,l). This indicates that there is an
overproduction of newly formed oligodendrocytes (CC1þ ) that
presumably never reach targets and die, similar to as occurs
during development31.
Together, these data reveal that the lesion provides an excellent
model to study the interactions between demyelinated axons and
OPCs in vivo, because at early timepoints, it lacks astrocytes and
is only populated by OPCs and macrophages; all OPCs within the
lesion have been recruited from surrounding areas; the axons are
healthy and electrically active; and all axons lacking myelin within
the lesion were previously myelinated.
Recruited OPCs express glutamate receptors. To test whether
adult OPCs recruited to areas of demyelination can sense
glutamate released from active axons, as they do during devel-
opment, we voltage-clamped OPCs within the lesion at 5–8 dpl in
acute brain slices containing the lesion (Fig. 1b). OPCs were
identiﬁed by their dye-ﬁlled morphology, electrophysiological
properties and by post-recording immunohistochemistry8
(Fig. 2a,b and see Methods). OPCs were both morphologically
and electrophysiologically distinct from macrophages
(Supplementary Fig. 2), which are large circular cells that lack
voltage-gated sodium currents typical of OPCs8 but have a slowly
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Figure 2 | Glutamate signalling in remyelinating lesions. (a) Voltage-clamped OPC, ﬁlled with lucifer yellow (LY) and identiﬁed after recording by
labelling for NG2 and Olig2 (scale bar, 10 mm) (b) with voltage-gated sodium currents (20mV steps from  74mV; inset: leak subtracted trace).
(c) Response of a recruited OPC to 100mM glutamate (Glu). (d) Mean peak current for glutamate-evoked currents in recruited OPCs (a specimen trace
shown in c) and macrophages (e–g). The glutamate-evoked current is unaffected by 200mM AP5 (P¼0.4, n¼ 6) but inhibited by 25mM NBQX
(P¼ 5 10 6, n¼ 7, one sample t-test). (h,i) AMPA (20 mM), kainate (30mM) and NMDA (60mM) evoked inward currents in OPCs. (j) Proportion of
OPCs with AMPA-evoked currents (in the ﬁrst week post lesion, 6 out of 6 cells recorded showed AMPA-evoked currents; in the second week, 13 out of 13
cells responded to AMPA) and NMDA-evoked currents; NMDA-evoked currents only became detectable in OPCs at the start of the second week post
lesion induction, P¼0.026 (w2-test with Yates correction, compared with the ﬁrst week; in the ﬁrst week, 0 out of 8 cells recorded had detectable NMDA-
evoked currents; for the second week, 8 out of 14 had detectable NMDA receptor responses). (k) Current–voltage relationship (voltage ramp from  134 to
þ 26mV) for glutamate-evoked current in OPCs (n¼ 7). (l–n) Glutamate-evoked [Ca2þ ]i rises in OPCs but not in macrophages (P¼6.2 10 5, Welch’s
corrected unpaired t-test, n¼ 11 and 6 cells, respectively, from 3 independent experiments) measured by taking the ﬂuorescent intensity ratio of Fluo-4/
FuraRed (low Ca2þ : red; high Ca2þ : green). Scale bar, 10 mm. Numbers of cells are indicated on bars, data represent means±s.e.m. in d,g,i,n.
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activating outward current at potentials above 40mV,
characteristic of microglia32,33 (Supplementary Fig. 2b,d).
Despite a small proportion of macrophages expressing NG2,
we never observed co-expression of Olig2 in these cells
(Supplementary Fig. 2e). Glutamate evoked an inward current
in NG2þ and Olig2þ OPCs (100 mM, 25.1±5.8 pA at
 74mV; Fig. 2c,d) but not in macrophages (Fig. 2d and
Supplementary Fig. 2c). The glutamate-evoked current in NG2þ
and Olig2þ OPCs was reduced by the selective AMPA (2-amino-
3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid)/kainate
receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione; 25 mM)34, but not the selective
NMDA (N-methyl-D-aspartate) receptor antagonist D-AP5
(D(-)-2-amino-5-phosphonovaleric acid; 200 mM)34 (Fig. 2e–g;
P¼ 5 10 6 and P¼ 0.4, respectively, one sample t-test, n¼ 7
and 6, respectively). Similarly, both AMPA (20 mM) and kainate
(30 mM), but not NMDA (60 mM), evoked an inward current in
OPCs (Fig. 2h,i). However, at the beginning of the second week
post lesioning, NMDA-evoked currents in OPCs could be
detected (Fig. 2j; NMDA currents were detected in 0 out of 8
OPCs in the ﬁrst week but in 8 out of 14 OPCs in the second
week; P¼ 0.026, w2-test with Yates correction), along with AMPA
receptor currents (detected in 6 out of 6 OPCs in the ﬁrst week
and in 13 out of 13 OPCs in the second week). This suggests that,
at the time of recruitment (the ﬁrst week post lesioning), OPCs in
the lesions mainly express AMPA and kainate receptors, making
them capable of sensing glutamate released from active neurons.
The positive rectiﬁcation of glutamate-evoked currents
in the recruited OPCs varied, with the rectiﬁcation index
[(Iþ 20mV Irev)/(Irev I 70mV)] ranging from 0.18 to 2
(Fig. 2k), indicative of OPCs expressing a variable mixture of
non-calcium-permeable and calcium-permeable AMPA recep-
tors35. Glutamate (100 mM) elicited a rise in intracellular calcium
concentration ([Ca2þ ]i) inB60% of OPCs (11 out of 18 cells) in
the lesions (Fig. 2l–n and Supplementary Fig. 3d,e) and only in
these cells were spontaneous [Ca2þ ]i spikes detected (Fig. 2m).
No [Ca2þ ]i changes or glutamate-evoked responses were
detected in macrophages (P¼ 6 10 5, Welch’s corrected
unpaired t-test, n¼ 6 for macrophages, n¼ 13 for OPCs;
Fig. 2l–n) or demyelinated axons (Supplementary Fig. 3d,e).
Given that at the time of OPC recruitment the lesion is devoid of
astrocyte cell bodies24 (Fig. 1h,i,l), these data indicate that at this
timepoint the OPCs are the only cells within the lesion capable of
responding to glutamate.
Demyelinated axons generate de novo synapses with OPCs.
During development, white matter OPCs receive synaptic
inputs6,8–10 from unmyelinated axons9,10, via postsynaptic
AMPA receptors36, and after demyelinating injury corpus
callosal axons generate synapses with recruited sub-ependymal
zone progenitors18 and OPCs19. However, as the majority of
corpus callosal axons are unmyelinated, we assessed whether
bona ﬁde demyelinated axons are capable of regenerating
synaptic inputs to OPCs by voltage clamping OPCs within
the EB lesion, where all axons were previously myelinated.
We detected spontaneous excitatory synaptic currents
(tdecay¼ 0.78±0.03ms, n¼ 15; Fig. 3a,d; in some OPCs,
outward currents were also detected, presumably mediated by
GABAergic input8), reminiscent of the EPSCs detected at a
similar frequency (P¼ 0.91, unpaired t-test, n¼ 6) in OPCs in the
mouse CCP at p7, at the start of myelination37 (Fig. 3b,d). In
contrast, when myelination was complete, in 3-month-old mice,
synaptic inputs were barely detected (in 1 out of 8 cells, a single
event above noise levels was detected compared with 7 out of 8
cells in young CCP with multiple events per cell; P¼ 0.01, w2-test
with Yates correction; Fig. 3b–d) and the total frequency of
synaptic events detected when myelination was complete was
0.16±0.16mHz compared with 10.8±3.7mHz during
development (P¼ 0.012, unpaired t-test, n¼ 8), indicating that
OPCs receive relatively few, if any, synaptic inputs in a white
matter tract that is fully myelinated. The events detected in
lesions were abolished by blocking action potentials with 1 mM
tetrodotoxin (TTX; Fig. 3e) and increased in frequency with 1 nM
a-latrotoxin, which, as expected for this concentration38,
promoted presynaptic neurotransmitter release by B2.5-fold
(3.1±0.6 versus 7.8±0.8mHz; P¼ 0.02, paired t-test, n¼ 4;
Fig. 3f,g)10. The pharmacological properties and the fast kinetics
of these inputs are identical to those of the synaptic inputs that
OPCs receive from unmyelinated axons9,10 and differ greatly
from what would be expected if generated by reversed cycling of
glutamate transporters10,39. Thus, these results indicate the
existence of deﬁned synaptic structures between recruited OPCs
and demyelinated axons, which form after demyelination.
To examine the pattern of expression of presynaptic terminals
within demyelinated lesions, we labelled for VGluT2, a marker for
glutamatergic presynaptic release sites known to be expressed
by neurons whose axons pass through the CCP40. In the
demyelinated lesion, there was clear punctate labelling for
VGluT2 (observed for seven lesions). In contrast, VGluT2
labelling was undetectable within the nearby normal-appearing
white matter (Fig. 3j) and in the adult white matter of unlesioned
animals (Fig. 3h). The punctate VGluT2 labelling seen in the
lesion was similar to that seen in the grey matter (Fig. 3h,j). The
intensity of neuroﬁlament labelling was unchanged between the
lesion and normal white matter areas (Fig. 3k), demonstrating
equal detection of intra-axonal proteins between myelinated and
demyelinated ﬁbres. Similar to what occurs for unmyelinated
axons during development, presynaptic formations occurred
along the demyelinated axons independent of OPC proximity9
(Fig. 3q, top panel), although strikingly, OPC processes seemed to
be preferentially located near VGluT2 puncta on the
demyelinated axons (Fig. 3l–q; observed for 196 NG2þ cells
with an average of 10±2 VGluT2 puncta per cell). Together,
these data strongly suggest that demyelinated axons establish de
novo synapses with recruited OPCs.
Synaptic transmission regulates remyelination. To examine the
functional importance of the synaptic input from the demyeli-
nated axons to the OPCs, we infused either 0.9% saline or an
antagonist to speciﬁcally block distinct stages of synaptic trans-
mission into the lesion via an intracerebral cannula, connected to
an osmotic minipump. Infusions into the lesion were from 3 dpl,
when OPCs are being recruited, to 21 dpl25 (see Methods and
Fig. 1j,l). We have previously shown that the delivery is local to
the lesion, as infusing dye into the lesion via osmotic minipump
results in the dye being conﬁned within the lesion41. First, we
infused 11 mM o-conotoxin MVIIC, a selective N-, P- and Q-type
calcium channel blocker42, to block vesicular release of
neurotransmitter, from 3 dpl. As the lesion is devoid of
astrocyte cell bodies24 (Fig. 1h,i,l), apart from axons only OPCs
and (monocyte- and microglia-derived) macrophages are present
and neither express functional N-, P- and Q-type voltage-gated
calcium channels43,44; thus, we attribute the effects of o-
conotoxin MVIIC to its action on demyelinated axons. Blinded
ranking analysis of remyelination, an established histological
analysis that assesses cross-sections of the entire lesion, revealed
that blocking vesicular neurotransmitter release signiﬁcantly
impaired remyelination compared with saline controls
(P¼ 0.01, Mann–Whitney rank analysis, n¼ 6 per group;
Fig. 4a,b,h), with fewer axons remyelinated (saline: 63±4%,
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o-conotoxin MVIIC: 23±5%; P¼ 5 10 4, unpaired t-test,
n¼ 6), but had no effect on lesion size (saline: 0.53±0.05mm2,
o-conotoxin MVIIC: 0.53±0.05mm2; P¼ 0.97, unpaired t-test,
n¼ 6 per group). This indicates that blocking vesicular release of
neurotransmitter reduces remyelination, similar to that during
development for myelination15,16.
Second, we blocked AMPA/kainate receptors, which are
expressed on the OPCs (Fig. 2) and are mainly located
postsynaptically at the axon-OPC synapse36, by infusing NBQX
from 3 dpl (250 mM; Fig. 4c,d,i), a selective AMPA/kainate
receptor antagonist that does not affect NMDA and metabotropic
glutamate receptors34, into the lesion. As macrophages do not
respond to glutamate (Fig. 2d,l–n and Supplementary Fig. 2c) and
demyelinated axons have not been reported to express AMPA
receptors (nor did we detect glutamate-evoked calcium changes
in demyelinated axons), we attribute the action of NBQX to
be on OPCs, presumably at the postsynaptic site. Blocking
AMPA/kainate receptors reduced remyelination (P¼ 0.039,
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Figure 3 | OPCs in remyelinating lesions receive synaptic inputs. (a) Recruited OPCs receive synaptic input from demyelinated axons (15/45 cells; inset:
specimen of a ﬁtted synaptic event), similar to (b) OPCs at the start of developmental myelination in the CCP of NG2-EYFP knock-in mice (seven out of
eight cells recorded; inset: specimen of a ﬁtted synaptic event), whereas (c) after myelination of the CCP is complete OPCs barely receive synaptic inputs
(one out of eight cells recorded; P¼0.01, w2-test with Yates correction compared with young CCP). (d) Average frequency of detected synaptic input in
OPCs in lesion (5–8 dpl), in the CCP at the start of myelination (p5–8 NG2-EYFP mice) and once myelination is complete (p98–105 NG2-EYFP mice). Data
are means±s.e.m., signiﬁcance tested by unpaired t-test, n¼6. The circles underneath the bar graph depict the proportion of OPCs with (black) and
without (white) synaptic inputs. (e) The synaptic inputs are blocked by 1 mM TTX. (f,g) a-Latrotoxin (a-LTX; 1 nM) increases the frequency of synaptic
events detected in OPCs (P¼0.02, paired Student’s t-test, all cell numbers are indicated on each bar graph, data are means±s.e.m.). (h) The presynaptic
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staining are increased in demyelinating lesions. Scale bar, 500mm. (k) Neuroﬁlament (NF) is equally detectable in normal and lesioned white matter. Scale
bar, 200mm. (l–n) OPCs establish synapses with demyelinated axons. Scale bar, 20mm. (o) Magniﬁcations of the cell in l–n. Scale bar, 5 mm. (p) Iso-surface
3D deconvolution of the cell in l–n generated using Imaris software, showing synapses located on the OPC processes. Scale bar, 20mm. (q) Top: synaptic
vesicles along a demyelinated axon; bottom: OPC extending processes towards VGluT2 vesicles. Scale bars, 5 mm.
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Mann–Whitney rank analysis, n¼ 7 per group) without affecting
lesion size (0.52±0.06mm2 (saline) versus 0.66±0.08mm2
(NBQX); P¼ 0.20, unpaired t-test, n¼ 7 per group).
This reduction in remyelination signiﬁcantly affected conduc-
tion speed through the lesion. We detected latency peaks
associated with conduction of myelinated ﬁbres in all lesions
infused with saline but detected only in 25% of lesions infused
with NBQX (Fig. 5b), which had a slightly slower conduction
speed (0.78±0.02m s 1 (saline) versus 0.67±0.02m s 1
(NBQX); P¼ 0.037, unpaired t-test, n¼ 4). The majority of
axons in NBQX-treated lesions were demyelinated, as 100% of
lesions had a latency peak associated with demyelinated axons (a
conduction speed of 0.34±0.02m s 1) compared with 75% of all
saline lesions (a conduction speed of 0.43±0.01m s 1;
P¼ 0.027, unpaired t-test, n¼ 4; Fig. 5b). The reduced recovery
of saline-treated lesions indicates that saline dilutes some essential
factors for remyelination, as a full recovery of the action potential
propagation is not fully established by 21 dpl in saline, unlike in
uninfused lesions (Fig. 1f,g). Nevertheless, the demyelinated
latency peak in NBQX-treated lesion had a far larger area
(0.03±0.00mV*ms (saline) versus 0.19±0.03mV*ms (NBQX);
P¼ 2.8 10 5, unpaired t-test, n¼ 4). The peak area reﬂects the
activity of all the stimulated axons and is thus directly
proportionate to the number of demyelinated axons, indicating
that there are many more demyelinated axons in NBQX-treated
samples. Together, these results demonstrate that AMPA/kainate
receptors are important for efﬁcient remyelination.
Previously, we have shown that blocking NMDA receptors
with MK-801, a highly selective open channel NMDA receptor
antagonist34, reduces remyelination13, similar to blocking AMPA
receptors or vesicular release of glutamate. As we only detect
NMDA receptor expression in OPCs at the second week post
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lesioning (Fig. 2j), at a time when OPCs are starting to
differentiate25 (Fig. 1k,l), but AMPA/kainate receptors are
expressed at early timepoints and directly involved in synaptic
transmission36, we hypothesized that AMPA/kainate receptors
are important for early stages of the remyelination process and
NMDA receptors for the later stages13. To test this hypothesis, we
blocked AMPA receptors at a time when OPCs start to
differentiate and NMDA receptors start to be expressed.
Blocking AMPA receptors at the second week post lesioning
did not affect remyelination (Fig. 5e–g; P¼ 0.86, Mann–Whitney
rank analysis, n¼ 4) unlike when blocking AMPA receptors from
3 dpl. These data along with our previous results13 indicate that
AMPA/kainate receptor activation is essential for the early stages
of remyelination, whereas NMDA receptors are important for
later stages of remyelination13.
Lastly, blocking neuronal activity in the lesion with 50 nM
TTX, from 3 dpl, reduced remyelination (Fig. 4e,f,j; P¼ 0.03,
Mann–Whitney rank analysis, n¼ 5) without affecting lesion size
(0.64±0.03mm2 (saline) versus 0.48±0.13mm2 (TTX);
P¼ 0.29, unpaired t-test, n¼ 5). At the ultrastructural level, it
was clear that signiﬁcantly fewer axons were remyelinated when
neuronal activity was blocked (P¼ 0.005, unpaired t-test, n¼ 3;
Fig. 6a,b). Blocking neuronal activity with TTX did not affect total
axonal number in the lesion (saline: 805161±93822 axons per
mm2, TTX: 649462±111669 axons per mm2; P¼ 0.31, unpaired
t-test, n¼ 3), but it did affect remyelination of smaller diameter
axons more than larger diameter axons (Po0.001, Kolmogorov–
Smirnov test, n¼ 3; Fig. 6f). In the few axons that were
remyelinated when neuronal activity was blocked, the g-ratio
(the ratio of axon diameter to the outside diameter of the myelin)
was higher compared with saline, indicating a thinner myelin
sheath (P¼ 0.003, unpaired t-test, n¼ 3; Fig. 6c–e); although the
myelin thickness was near identical for larger-diameter axons
(axonal diameter Z2mm, g-ratio saline: 0.93±0.005, TTX:
0.93±0.002; P¼ 0.95, unpaired t-test, n¼ 3 lesion), it was
markedly thinner for small-diameter axons (axonal diameter
o2 mm, g-ratio saline: 0.86±0.002, TTX: 0.88±0.002;
P¼ 4 10 6, unpaired t-test, n¼ 3 lesions). Together, this
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shows that efﬁcient remyelination, especially at smaller-diameter
axons, depends on neuronal activity and the synaptic commu-
nication between demyelinated axons and OPCs.
Neuronal activity regulates OPC differentiation. OPC migra-
tion and proliferation can be regulated by neuronal activity18,45,46
and glutamate12,47,48. Therefore, we investigated whether
blocking neuronal activity with TTX affected OPC recruitment
by staining lesions for NG2 and Olig2. Remarkably, there was a
6-fold increase in the number of OPCs (deﬁned as NG2þ and
Olig2þ cells) in the TTX-treated lesions compared with saline
controls (33±9 versus 222±22 cells per mm2; P¼ 4 10 8,
Welch’s corrected unpaired t-test, TTX: n¼ 4 and saline: n¼ 3)
and a 2.7-fold increase in Olig2þ cells (Fig. 7a,b; P¼ 5.8 10 7,
Welch’s corrected unpaired t-test, TTX: n¼ 4 and saline: n¼ 3),
with a higher proportion of Olig2þ cells being NG2þ OPCs
(Fig. 7c,d; P¼ 0.016, Welch’s corrected unpaired t-test, TTX:
n¼ 4 and saline: n¼ 3) and a lower proportion being CC1þ
oligodendrocytes (Fig. 7e,f; P¼ 1 10 6, Welch’s corrected
unpaired t-test, TTX: n¼ 4 and saline: n¼ 3). The increase in
OPCs at 14 dpl is due to a higher proliferation of OPCs at early
time points, as we detected nearly 2-fold increase in EdUþ
Olig2þ cells (5-ethynyl-2’-deoxyuridine (EdU) delivered
continuously for 3 days; Fig. 7g; P¼ 0.023, Welch’s corrected
unpaired t-test, TTX: n¼ 2 and saline: n¼ 3) and a 3.5-fold
increase in Ki-67þ Olig2þ cells (Fig. 7h; P¼ 1.5 10–3, Welch’s
corrected unpaired t-test, TTX: n¼ 3 and saline: n¼ 2) at 5 dpl,
but no difference at 14 dpl (Fig. 7i; P¼ 0.43, Welch-corrected
unpaired t-test, n¼ 3). The increase in proliferation of OPCs at
early timepoints may reﬂect the fact that suppressing glutamate
release removes a signal that normally limits OPC
proliferation12,49.
Despite a lower proportion of Olig2þ cells being CC1þ in
TTX-treated lesions, there was no difference in the absolute
density of CC1þ cells between the conditions (P¼ 0.25, Welch’s
corrected unpaired t-test, TTX: n¼ 4 and saline: n¼ 3). Never-
theless, signiﬁcantly fewer axons were remyelinated in TTX-
treated lesions a week later (P¼ 0.005, Welch’s corrected
unpaired t-test, n¼ 3; Fig. 6a,b), indicating that a large
proportion of these CC1þ oligodendrocytes fail to myelinate.
As newly differentiated premyelinating oligodendrocytes depend
on axonal signals for survival50,51, we tested whether neuronal
activity affects cell survival by examining the expression of
caspase 3, a marker for apoptosis52, in Olig2þ oligodendrocyte
lineage cells. Blocking neuronal activity increased apoptosis by
B40% compared with saline (Fig. 7j; 12±3% (saline) versus
16±5% (TTX); P¼ 0.04, Welch’s corrected unpaired t-test,
n¼ 3) in Olig2þ cells. Together, these results indicate that the
failure of remyelination that occurs when neuronal activity is
blocked is not caused by reduced OPC recruitment but by an
increase in apoptosis and impaired differentiation towards
myelinating oligodendrocytes.
Human demyelinated axons upregulate synaptic proteins. To
determine the signiﬁcance of our ﬁnding for human white matter
disease, we examined the expression of VGluT2 in human MS
lesions and adjacent normal-appearing white matter (or non-
demyelinated white matter). Similar to the rodent demyelinated
lesions, there was an approximately sixfold increase in VGluT2
expression in the human MS lesions compared with the normal-
appearing white matter (Fig. 8a–e; P¼ 4.1 10 7, unpaired
t-test, n¼ 5 lesions from 5 patients) and the VGluT2 puncta were
observed in close proximity of NG2þ cells present in the MS
lesions (Fig. 8f,g; detected for 150 NG2þ cells), with NG2þ
processes nearly always located near the VGluT2 puncta. Toge-
ther, these results strongly suggest that, after white matter injury,
demyelinated axons establish de novo synapses with recruited
OPCs in humans.
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Discussion
Remyelination is essential for functional recovery after demye-
linating injury. However, spontaneous remyelination often fails,
primarily due to failure of OPC differentiation rather than OPC
depletion5,53,54. Here we have shown that glutamatergic synaptic
transmission between demyelinated axons and OPCs, acting via
AMPA receptors, regulates remyelination, and that blocking
neuronal activity keeps OPCs in a proliferative stage, preventing
them from fully differentiating into myelinating oligodendrocytes.
This may explain why remyelination fails in disease.
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We found that following demyelination of a CNS white matter
tract where all the axons were previously myelinated, recruited
OPCs receive synaptic inputs from demyelinated axons. On
demyelination, axons increase their expression of the pre-synaptic
protein VGluT2 and generate de novo synapses with recruited
OPCs. We found that a similar mechanism may also occur in
human MS lesions. At early timepoints after entering the lesion,
the recruited OPCs express mainly AMPA and kainate receptors,
presumably at the postsynaptic site. The role of the synaptic input
to OPCs seems to be instructing them to remyelinate, as when we
infused antagonists speciﬁc to distinct stages of synaptic
transmission (o-conotoxin MVIIC to block vesicular release of
neurotransmitter, NBQX to block postsynaptic AMPA receptors
on the OPCs and TTX to block voltage-gated Naþ channels and
thus neuronal activity) into the lesion, all of them impaired
remyelination.
Two lines of evidence show that the antagonists are acting
locally within the lesion. First, when a dye is infused into a lesion
with an osmotic minipump (even with a faster ﬂow rate and larger
volume delivered than used in this study) the dye remains within
the lesion41. Second, no side effects were detected, such as severe
disruption of motor function, which would be expected if TTX
were to spread into the nearby grey matter beyond the lesion. The
lesion model we used is initially devoid of astrocytic cell bodies24
and is only occupied by macrophages, OPCs and demyelinated
axons (whose cell bodies are distant). Therefore, the antagonist
infused into the lesion should be cell speciﬁc, as neither OPCs43
nor macrophages44 express functional N-, Q- and P-voltage-gated
calcium channels, blocked by o-conotoxin MVIIC. Similarly,
macrophages in the lesion do not respond to glutamate and
demyelinated axons have not been reported to express AMPA
receptors (nor did we detect glutamate evoked calcium changes in
demyelinated axons); thus, NBQX infusion into the lesion should
only affect the AMPA receptors on OPCs. Furthermore, as
administrating NBQX later, at the time when astrocytes have
reappeared in the lesion24, did not affect remyelination, we can
attribute the effect of NBQX administration to an effect on OPC
AMPA receptors. By combining three distinct antagonists of
synaptic transmission, all of which give the same results, we were
able to demonstrate a role for synaptic communication between
axons and OPCs in regulating remyelination in vivo.
Despite our demonstration that NBQX blocks remyelination,
paradoxically, a systemic administration of NBQX to EAE mice
was found to ameliorate the clinical severity of the disease21,22.
This may reﬂect neuroprotection from glutamate excitotoxicity
induced by the severe inﬂammation occurring in EAE lesions7,55.
In contrast, we used local administration of NBQX into the white
matter of a model that fully remyelinates without signiﬁcant
axonal loss, thereby identifying a mechanism of white matter
regeneration rather than of white matter damage.
Blocking neuronal activity with TTX, which blocks voltage-
gated Naþ channels, reduced remyelination in a similar manner
to blocking vesicular release of neurotransmitter with o-conotoxin
MVIIC or to blocking with NBQX the AMPA/kainate receptors,
located postsynaptically at the axon-OPC synapse36. This resulted
in fewer axons being remyelinated, with smaller diameter axons
being more affected, just as blocking vesicular release of
neurotransmitter preferentially affects myelination of small-
diameter axons16. We assume that the effects of TTX are
predominantly to block axonal action potentials. However,
OPCs also express voltage-gated Naþ channels and it is
currently unknown what role they have in OPC biology.
Although, we cannot exclude an effect of TTX on voltage-gated
Naþ channels in OPCs, activation of OPC Naþ channels requires
the membrane to become depolarized to B 40mV, which is
unlikely to occur without activity-driven input.
The lack of activity-driven signals in the TTX-treated samples
caused an up to 3.5-fold increase in proliferation of OPCs at 5
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dpl, resulting in a B6-fold increase in NG2- and Olig2-positive
cells at 14 dpl, indicating that blocking neuronal activity
predominantly keeps OPCs in a proliferative stage and leads to
a lower proportion of differentiated oligodendrocytes. However,
the absolute numbers of differentiated oligodendrocytes (CC1þ )
at 14 dpl remain the same. Intriguingly, despite equal numbers
there is less remyelination. In our lesion model we see an
overproduction of CC1þ cells at 14 dpl that presumably do not
reach targets, as there are fewer CC1þ cells at 21 dpl, comparable
to early development where there is an overproduction of
oligodendrocytes, many of which die31. This possibly reﬂects a
spontaneous differentiation of OPCs, which occurs at high OPC
density56. Thus, a higher proportion of untargeted differentiation,
owing to higher OPC density, could explain why equal numbers
of CC1þ cells still lead to impaired remyelination in TTX-treated
lesions.
The effect of blocking the activity of the demyelinated axons is
likely to be mediated via synaptic input and glutamate release, as
blocking vesicular release and AMPA receptors on OPCs also
resulted in impaired remyelination. Previously, we showed
remyelination depended on activation of NMDA receptors13,
but NMDA-evoked currents in OPCs only appear at the second
week post lesion induction, which suggests that NMDA receptors
only play a role at later stages of remyelination. Conversely,
AMPA/kainate receptors are expressed throughout the
regenerative process57 and activation of AMPA receptors
during the period of proliferation is essential for remyelination,
whereas activation of AMPA receptors later, at the onset of
differentiation (a time when NMDA-evoked currents start to be
detected), is not. Thus, using this remyelination model we have
revealed a potential distinct role for different glutamate receptors
expressed on OPCs. Presumably, glutamate released at the axon-
OPC synapse activates the AMPA receptors directing OPCs
towards the axon to myelinate, as synaptic inputs are important
for axonal selection15,16. Once the axon-OPC contact is made,
NMDA receptors (as they tend to be expressed on the
processes6,58) become important to direct myelination13. Our
data therefore suggest that neuronal activity ﬁne-tunes OPC
proliferation and times the onset of OPC differentiation by acting
on AMPA receptors and regulates remyelination by acting on
NMDA receptors. Thus, when OPCs do not receive synaptic
inputs from active demyelinated axons they remain in a
proliferative state, because they lack their inductive signal to
differentiate.
Remyelination efﬁciency decreases with age, as a result of a
failure of differentiation59,60 rather than OPC depletion5,59,61.
Our data indicate that for remyelination to occur the
demyelinated axons must recapitulate early development and
direct OPC differentiation by maintaining electrical activity to
release glutamate onto OPCs. In fact, on demyelination, axons
switch their isoform of voltage-gated sodium channels (Nav) from
Nav1.6 (found at the nodes of myelinated axons62) back to Nav1.2
(ref. 63) (found in unmyelinated axons during development62).
Furthermore, in active MS lesions (many of which undergo
remyelination), axons express Nav1.2 channels64,65 and
upregulate synaptic proteins19, whereas axons in chronic lesions
that have failed to remyelinate do not64. This, together with our
results, suggests a commonality of response by injured axons: the
demyelinated axons undergo a similar response to that of
transected peripheral axons, which by reactivating silent growth
programmes revert to a developmental state for efﬁcient
regeneration66. Our results indicate that any perturbation of
signals that induce demyelinated axons to remain active and/or
regain synaptic contacts with recruited OPCs will result in a
failure of OPC differentiation and repair. Consistent with our
data, OPCs are present in chronic lesions5, presumably lacking an
inductive signal from the demyelinated axons for differentiation.
Hence, it is conceivable that the use of agonists that promote
impulse propagation, vesicular release and/or AMPA receptor
currents in OPCs may promote OPC differentiation and myelin
repair in disease. Thus, our results reveal a missing link for
understanding myelin regeneration and open up new and
pharmacologically tractable avenues by which the arrest of OPC
differentiation in chronic MS lesions could be therapeutically
reversed.
Methods
Toxin-induced focal demyelination. Female Sprague–Dawley rats aged 10–14
weeks of age (190–250 g) were used. Experiments were performed in compliance
with UK Home Ofﬁce regulations. In this toxin model, remyelination proceeds to
completion (between 3 and 4 weeks after induction of the lesion) with a clear
temporal separation between the acute demyelination phase and the subsequent
stages of remyelination: OPC recruitment (3–10 dpl), differentiation (10–14 dpl)
and remyelination (21–28 dpl)25. For electrophysiological experiments, focal
demyelination was induced bilaterally by injection of EB into the CCP24 and
animals were culled by decapitation. Brieﬂy, anaesthesia was induced (4%) and
maintained (1.5%–2.5%) with isoﬂurane (Henry Schein, Animal Health, Dumfries,
UK) and the animal placed in a stereotaxic frame. After incision of the skin, holes
were drilled at stereotaxically deﬁned locations, then a Hamilton syringe lowered in
place to inject 4.0 ml of 0.01% EB (w/v) in 0.9% saline (Vetivex) at 1 ml min 1. The
skin was sutured using Vicryl 5.0 (Henry Schein). Analgesia was provided by
injection of buprenorphine (0.005mg per 100 g body weight, Vetergesic) before
surgery and orally (1 g 10% Vetergesic in ﬂavoured jelly per 100 g body weight)
twice a day, up to 2 days until full recovery. Animals were monitored twice daily
until full recovery. For continuous local delivery, unilateral lesions were performed
and blockers (Tocris), dissolved in 0.9% saline, were infused into the demyelinated
lesion by an osmotic minipump, with a reservoir volume of 100ml and a ﬂow rate
of 0.11 ml h 1 (Alzet Micro-Osmotic Pumps, model 1004, DURECT Corporation),
which was attached through a vinyl tube spacer (Plastics One Inc., Roanoke,
Virginia) to a 30-gauge (6.5mm) cannula implanted just above the lesion. The
minipump was placed subcutaneously and the cannula was ﬁxed to the skull with
cyanoacrylate gel adhesive (applied under the base of the cannula head before
insertion), as well as two anchoring screws and dental acrylic cement (a 1:1 volume
mix of Palacos MGþG powder and liquid, Heraeus Kulzer)13. Drug delivery into
the lesion did not occur until 3 dpl (the start of the OPC recruitment stage25;
Fig. 1l) or at 10 dpl (at the start of OPC differentiation25; Fig. 1l). The onset of drug
delivery into the lesion was controlled by varying the length of the tube that
connects the minipump to the cannula and by inserting a sterile corn oil drop
(Sigma) to prevent diffusion of the drug solution into the initial saline solution. For
proliferation studies at 5 dpl, EdU was administered by osmotic minipump,
dissolved as 5 mg ml 1 of saline solution, from 3 dpl. We have previously shown
that the delivery is local with no signiﬁcant dye diffusion detectable outside the
lesion41. Rats were randomly assigned to treatment (o-conotoxin MVIIC, 11 mM;
NBQX, 250 mM; TTX, 50 nM) or control groups (0.9% saline infusion). Samples
were included in the analysis only if the cannula was found within 200 mm of the
lesion. For remyelination studies, animals were perfuse ﬁxed under terminal
anaesthesia (pentobarbitone sodium) 3 weeks after lesion induction.
Acute brain slices for electrophysiology and Ca2þ imaging. For the majority of
the experiments, rat sagittal slices (225 mm for patch clamping and Ca2þ imaging,
300 mm for compound action potential) including the CCP containing the lesion
were made, either between 5 and 10 dpl, when OPC numbers within the lesion
peak, or at 21 dpl, when remyelination is near completion25. For the recordings of
synaptic input in normal adult white matter at P5–P7 and P98–P105 (3 months
old), slices were obtained from NG2-EYFP knock-in male and female mice67 with
the same procedure. Slices were made in an ice-cold bicarbonate-buffered (5%
CO2/95% O2, pH 7.4) slicing solution containing (mM): 120 NaCl, 26 NaHCO3,
1 NaH2PO4, 2.5 KCl, 2 MgCl2, 2 CaCl2, 10 glucose and 1 kynurenic acid
(a broad-spectrum glutamate receptor antagonist). For all experiments, slices were
superfused at 22±1 C with HEPES-buffered solution containing (mM): 144 NaCl,
2.5 KCl, 10 HEPES, 1 NaH2PO4, 2.5 CaCl2, 10 glucose, 0.1 glycine (to co-activate
NMDA receptors), 0.005 strychnine (to block glycine receptors), pH adjusted to 7.4
with NaOH and bubbled with 100% O2.
Whole-cell patch clamp recordings. Whole-cell patch clamp recordings were
conducted using Multiclamp 700B (Molecular Devices) connected to a 16-bit
analogue-to-digital converter (Digidata 1440A, Molecular Devices). The pClamp
10 software package was used for data acquisition (sampling rate 50 kHz, ﬁlter
10 kHz) and analysis. Electrodes contained solution comprising (mM): 130 Cs-
gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 BAPTA, 4 MgATP, 0.5 Na2GTP, 2 K-
Lucifer yellow, pH set to 7.3 with CsOH, 295mOsm. Series resistance was 5–25MO
(if higher, cells were excluded from the analysis) and electrode junction potentials
( 14mV) were corrected for. Cells were identiﬁed (Fig. 2a,b and Supplementary
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9518
12 NATURE COMMUNICATIONS | 6:8518 | DOI: 10.1038/ncomms9518 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Fig. 2) by their post-recording dye-ﬁll morphology8,68 and conﬁrmed by antibody
labelling against proteoglycan NG2 (11/11) and the transcription factor Olig2 to
identify oligodendrocyte progenitors (16/16). OPCs had a steady-state input
resistance of B900MO and a low cell capacitance of 31.6±3 pF. OPCs were
deﬁned both by morphology and in some cases by labelling with antibodies against
NG2 and Olig2, and were electrophysiologically and morphologically distinct from
the abundant macrophages in 5–10 dpl lesions (Supplementary Fig. 2).
Synaptic current analysis. A synaptic current was deﬁned to occur if its ampli-
tude was 43 times the s.d. of the baseline current noise and its 10%–90% decay
time was longer than its rise time. Events were recorded using a Minidigi 1B
(Molecular Devices, sampling 1 kHz), then detected and analysed with
WinEDRv3.2.6 and WinWCP v4.3.7 (University of Strathclyde).
Compound action potential recordings. Stimulation was delivered by a voltage
stimulator (Digitimer) through tungsten bipolar electrodes (WPI) and recorded
with a glass electrode (0.8–1MO) ﬁlled with external HEPES-buffered solution
connected to an ampliﬁer (Multiclamp 700B). At the end of each experiment,
different lipophilic dyes (DiD and DiI, Molecular Probes) were applied to mark the
stimulation (DiD) and recording (DiI) electrode location (Fig. 1c). The distance
between the electrodes was measured using Image J.
Intracellular Ca2þ imaging. Slices were incubated for 1 h at 22 C in slicing
solution with 10mM Fluo4-AM, 25 mM FuraRed-AM and 0.25% pluronic F-127
(Life Technologies), followed by 1 h de-esteriﬁcation. Fluorescence was excited at
488 nm by scanning laser (Leica Sp5,  40 water-immersion objective with 0.80
numerical aperture) and emitted light was collected at 489–583 nm for Fluo4 and at
622–703 nm for FuraRed. The ratio of the emission intensities of Fluo4 (maximum
emission when bound to Ca2þ ) and FuraRed (maximum emission when Ca2þ is
free) was used to measure the increase in [Ca2þ ]i and only ratios that reﬂected
both an increase of ﬂuorescence emitted at 489–583 nm and a decrease in ﬂuor-
escence emitted at 622–703 nm were used. After imaging, three morphologically
distinct cells were dye-ﬁlled via patch pipette for post-hoc identiﬁcation of the area
imaged, and to allow for identiﬁcation of the cell types within the imaged area with
immunohistochemistry (Supplementary Fig. 3a–c).
Immunohistochemistry. Fixed slices were incubated for 5 h in 0.5% Triton X-100,
10% goat serum in PBS at 21 C, then with primary antibody at 21 C overnight,
and then for 5 h at 21 C with secondary antibody; both antibody incubations were
followed by three 20-min washing steps in PBS. Cryostat sections were incubated
for 1 h in 0.1% Triton X-100, 10% goat or donkey serum in PBS at 21 C, then with
primary antibody at 4 C overnight (apart from goat Olig2, which was incubated
for 5 h at 21 C), and then for 1 h at 21 C with secondary antibody. All antibodies
(primary and secondary) used have been previously used and validated in our
laboratories13,57,69. Primary antibodies were as follows: rabbit caspase-3 (Millipore:
AB3623, 1:10), rabbit GFAP (DAKO: Z0334, 1:200), guinea pig NG2 (a kind gift
from W.B. Stallcup: 1:400), rabbit NG2 (Millipore: AB5320, 1:300), mouse NG2
(Millipore: MAB5384, 1:250), rabbit Olig2 (Millipore: AB9610, 1:300), goat Olig2
(R&D Systems: AF2418, 1:200), guinea pig VGluT2 (Synaptic System: 135 404,
1:500), mouse neuroﬁlament 160/200 (Sigma: N2912, 1:200), mouse CC1
(Calbiochem: OP80, 1:200), rabbit ki-67 (Abcam: AB16667, 1:300) and mouse
CD11b (Serotec: MCA711, 1:100). 4,6-diamidino-2-phenylindole (10min, D9542,
Sigma, 1 mgml 1) was used to label nuclei. Secondary antibodies (goat) were for
rabbit IgG (Life Technologies: A11034, A11036 and A21245, 1:500), guinea pig IgG
(Life Technologies: A21435, 1:500) and mouse IgG (Life Technologies: A11029,
A11031 and A21236, 1:500). Secondary antibodies (donkey) were for goat IgG
(Sigma: SAB4600032, 1:500) and rabbit IgG (Life Technologies: A-31573, 1:500).
Samples to be immunolabelled with GFAP and Ki-67 underwent antigen retrieval,
by incubation at 80 C for 20min in citrate buffer (10mM sodium citrate, 0.05%
Tween 20, pH 6.0), before the immunohistochemistry procedure outlined above.
EdU was detected using a Click-iT EdU Alexa Fluor 555 Imaging Kit (Life
Technologies, C10338), according to the manufacturer’s instructions. Brieﬂy,
antigen retrieval was carried out as described, sections were permeabilized for 1 h
with 0.05% Triton in PBS, washed for 15min in 2% BSA in PBS, then Click-iT
reaction cocktail applied for 30min, sections were washed again with 2% BSA, then
the immunohistochemistry procedure continued as described above. Coverslips
were mounted with Fluoromount-G. For quantitative analysis, the whole lesion
(three sections with lesions per animal) was photographed and each picture given a
number. Random numbers were generated to select the pictures to be analysed
blindly (4 to 6 pictures per animal, minimum 12 pictures for each condition).
Human tissue immunohistochemistry. Postmortem MS tissues were obtained
from the UK MS Society Tissue Bank at Imperial College and were collected via a
prospective donor scheme following fully informed consent (08/MRE09/31). The
demographic data and clinical characteristics are shown in Supplementary Table 1.
The clinical diagnosis of MS was conﬁrmed based on the patient history and a
detailed neuropathological analysis. The presence of lesions was conﬁrmed as
described previously70. Ten-micrometre sections from snap-frozen human tissue
blocks were permeabilized with methanol at  20 C for 15min, sections were
incubated for 1 h in 0.1% Triton X-100, 10% goat serum in PBS at 21 C, then with
primary antibody at 4 C overnight, and then for 2 h at 21 C with secondary
antibody. Primary antibodies were rabbit NG2 (as above, 1:100), guinea pig
VGluT2 (as above, 1:500), rabbit MOG (1:10, in house) and mouse neuroﬁlament
(as above, 1:1,000), and all secondary antibodies as above. 4,6-diamidino-2-
phenylindole (10min, Sigma, 100mgml 1) was used to label nuclei and
autoﬂuorescence quenched with 0.1% Sudan Black for 30min. Coverslips were
mounted with Vectashield. All images were 5 mm z-stacks taken at 0.5 mm intervals
on a Leica EL6000 confocal microscope. For VGluT2 quantiﬁcation, white matter
lesions were identiﬁed using a sequential section stained for MOG by
immunohistochemistry. Lesion edges were deﬁned by the abrupt absence of
MOGþ myelin in anatomically aligned tracts with continuing axons. Sections were
aligned and white matter lesions outlined on ﬂuorescently stained slides. For each
MS case, one white matter lesion that contained a high number of NG2þ cells was
analysed. The presence of axons within the lesion was conﬁrmed by neuroﬁlament
staining. For quantitative analysis, all images were taken at  63 at the same gain,
resolution and exposure settings within lesions and adjacent areas of normal-
appearing white matter based on the MOG staining. A further sequential section
was stained with the same protocol as above for MOG (1:10, in house) and VGluT2
(1:500), to conﬁrm lesion localization. After acquisition, all images were analysed
blindly (three images per lesion and one lesion per patient), by a different person to
the one who had acquired the images.
Histological analysis of demyelination and remyelination. Animals were per-
fused with 4% glutaraldehyde (in phosphate buffer with 0.72mM CaCl2) and the
brains left to post ﬁx for 4–7 days. Tissue blocks encompassing the CCP were cut24.
Blocks were processed through 2% osmium tetroxide (Oxkem Ltd), dehydrated in
increasing concentration of ethanol and embedded in resin (TAAB Laboratories).
One-micrometre sections were cut using a Leica microtome (RM 2065) and stained
with Toluidine blue. In these sections, remyelinated axons can be easily
distinguished from normally myelinated axons outside the lesion by the thinness of
the myelin sheath and remyelinated axons can be distinguished from demyelinated
axons (Supplementary Fig. 1). Remyelination was independently ranked blindly by
three persons.
Electron microscopy. Samples used for histological analysis were further pro-
cessed for electron microscopy. Resin blocks were cut in 90-nm sections on an
ultramicrotome (Reichert Ultracut E) with a diamond knife (Diatome) and
visualized using a transmission electron microscope (Hitachi H600). Random
images (saline n¼ 10 and TTX n¼ 12) from the lesions were taken and developed
on Electron Microscope Film 4489 (Kodak), then scanned at high resolution
(12,800 dpi 12,800 dpi). The number of axons remyelinated and their g-ratios
(the ratio of axon diameter to the outside diameter of the myelin) were analysed
with ImageJ software (version 1.45 s) by blinded analysis. A total of 302 (TTX) and
312 (saline) axons were analysed.
Statistics. Numbers of experiments are indicated on bars. Data are presented as
mean±s.e.m., unless stated otherwise. When relevant, normality of data was
assessed using Shapiro–Wilk tests. Non-parametric tests that do not assume data
follow a normal distribution gave the same conclusions for signiﬁcant and non-
signiﬁcant differences in all cases. One-way ANOVA followed by Holm–
Bonferroni-corrected post-hoc t-tests were used to compare multiple samples.
Other P-values for comparison of means are from Student’s two-tailed t-tests, with
Welch’s correction when variances were unequal. Ranking was analysed with
Mann–Whitney ranking tests. Analysis of covariance was used to analyse regres-
sion lines. Cumulative frequency was analysed with Kolmogorov–Smirnov tests.
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